Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Requests Waiver on Existing Credit Agreement

NEW YORK (GenomeWeb News) – Life Technologies disclosed in a filing with the US Securities and Exchange Commission yesterday that it has requested a waiver under an existing credit agreement with lenders dated Nov. 21, 2008.

If approved, the waiver would enable Life Technologies to incur indebtedness in the form of unsecured, fixed-rate or floating-rate securities, in one or more series. The firm would use the proceeds to prepay term loan indebtedness under the credit agreement.

The parties to the credit agreement include Bank of America as administrative agent, UBS Securities and Morgan Stanley Senior Funding as co-syndication agents, and DnB Nor Bank and the Bank of Nova Scotia as co-documentation agents.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more